Total Payments
$414,661
2024 Payments
$160,057
Companies
31
Transactions
897
Medicare Patients
27,510
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$325,099 (78.4%)
Travel$56,869 (13.7%)
Food & Beverage$20,651 (5.0%)
Consulting$6,094 (1.5%)
Research$5,230 (1.3%)
Education$719.30 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $325,099 | 215 | 78.4% |
| Travel and Lodging | $56,869 | 97 | 13.7% |
| Food and Beverage | $20,651 | 557 | 5.0% |
| Consulting Fee | $6,094 | 12 | 1.5% |
| Unspecified | $5,230 | 5 | 1.3% |
| Education | $719.30 | 11 | 0.2% |
Payments by Type
General
$409,431
892 transactions
Research
$5,230
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $139,387 | 154 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $69,399 | 147 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $55,095 | 65 | $0 (2022) |
| UCB, Inc. | $54,921 | 119 | $0 (2024) |
| GENZYME CORPORATION | $30,233 | 62 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $29,079 | 63 | $0 (2024) |
| ABBVIE INC. | $22,711 | 90 | $0 (2024) |
| Lilly USA, LLC | $9,989 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $806.08 | 46 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $558.49 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $160,057 | 273 | Janssen Biotech, Inc. ($57,117) |
| 2023 | $122,957 | 243 | Janssen Biotech, Inc. ($80,333) |
| 2022 | $84,365 | 224 | Janssen Scientific Affairs, LLC ($35,251) |
| 2021 | $47,282 | 157 | Janssen Scientific Affairs, LLC ($19,844) |
All Payment Transactions
897 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: Immunology | ||||||
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Immunology | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.02 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | Cash or cash equivalent | $156.78 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | Cash or cash equivalent | $30.75 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | Cash or cash equivalent | $24.87 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Dermatology | ||||||
| 12/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $326.57 | General |
| Category: Immunology | ||||||
| 12/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,772.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 12/05/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $119.85 | General |
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $49.73 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,363.00 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $120.68 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $924.00 | General |
| Category: Immunology | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: Immunology | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Immunology | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $760.00 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Chronic Plaque Psoriasis (Ps) Registry | ABBVIE INC. | $3,440 | 2 |
| Chronic Plaque Psoriasis (Ps) Registry | AbbVie Inc. | $1,360 | 2 |
| A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA (Adalimumab) in Adult Patients with Chronic Plaque Psoriasis (PS) | ABBVIE INC. | $430.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 6,161 | 11,630 | $1.5M | $445,984 |
| 2022 | 30 | 6,608 | 11,764 | $1.1M | $433,275 |
| 2021 | 34 | 7,137 | 12,848 | $1.1M | $484,052 |
| 2020 | 36 | 7,604 | 13,162 | $1.1M | $453,712 |
Total Patients
27,510
Total Services
49,404
Medicare Billing
$1.8M
Procedure Codes
133
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,853 | 2,850 | $511,181 | $147,631 | 28.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,055 | 1,555 | $206,062 | $51,570 | 25.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 672 | 825 | $164,449 | $48,858 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 262 | 311 | $78,988 | $24,194 | 30.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 43 | 63 | $49,266 | $19,312 | 39.2% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 54 | 63 | $54,855 | $17,673 | 32.2% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 54 | 101 | $52,389 | $17,456 | 33.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 731 | 3,987 | $51,406 | $16,053 | 31.2% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 74 | 357 | $28,096 | $11,013 | 39.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 147 | 159 | $35,353 | $10,335 | 29.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 170 | 170 | $38,144 | $10,252 | 26.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 260 | 291 | $32,567 | $9,632 | 29.6% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 39 | 50 | $22,079 | $7,219 | 32.7% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 25 | 27 | $21,265 | $6,619 | 31.1% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 85 | 86 | $20,715 | $6,037 | 29.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 38 | 53 | $17,710 | $5,239 | 29.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 116 | 159 | $15,755 | $5,102 | 32.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 40 | 44 | $15,582 | $4,692 | 30.1% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 43 | 43 | $11,651 | $3,256 | 27.9% |
| 69100 | Biopsy of ear | Office | 2023 | 53 | 56 | $10,725 | $2,810 | 26.2% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 32 | 33 | $8,943 | $2,759 | 30.8% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 55 | 63 | $8,162 | $2,724 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $8,665 | $2,707 | 31.2% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 31 | 33 | $7,601 | $2,302 | 30.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 25 | 27 | $6,702 | $2,154 | 32.1% |
About Brian Bonomo, PAC
Brian Bonomo, PAC is a Physician Assistant healthcare provider based in Lecanto, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124012596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Bonomo, PAC has received a total of $414,661 in payments from pharmaceutical and medical device companies, with $160,057 received in 2024. These payments were reported across 897 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($325,099).
As a Medicare-enrolled provider, Bonomo has provided services to 27,510 Medicare beneficiaries, totaling 49,404 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Lecanto, FL
- Active Since 08/31/2005
- Last Updated 11/12/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1124012596
Products in Payments
- TREMFYA (Drug) $189,811
- DUPIXENT (Biological) $95,213
- Bimzelx (Biological) $46,489
- Sotyktu (Drug) $27,450
- SKYRIZI (Biological) $17,058
- OLUMIANT (Drug) $9,433
- HUMIRA (Biological) $5,281
- SIMPONI ARIA (Biological) $4,544
- Cimzia (Drug) $2,643
- VTAMA (Drug) $544.92
- Otezla (Drug) $463.82
- COSENTYX (Biological) $434.14
- RINVOQ (Biological) $340.54
- TALTZ (Drug) $330.85
- COSENTYX (Drug) $328.74
- Kerecis Omega3 SurgiClose (Device) $299.26
- ADBRY (Biological) $290.85
- Odomzo (Drug) $146.68
- ILUMYA (Biological) $135.87
- REMICADE (Biological) $127.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Lecanto
Mujiba Ansari, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $8,275
Physician Assistant $8,275
Patricia Spitzer, Pa, PA
Physician Assistant — Payments: $4,166
Physician Assistant $4,166
Keely Staten, Pa-C, PA-C
Physician Assistant — Payments: $2,524
Physician Assistant $2,524
Sarah Joerres, Pa-C, PA-C
Physician Assistant — Payments: $2,060
Physician Assistant $2,060
Kendel Vickers, Pa-C, PA-C
Physician Assistant — Payments: $1,713
Physician Assistant $1,713
Hollie Saylor, Pa-C, PA-C
Physician Assistant — Payments: $1,248
Physician Assistant $1,248